AIM ImmunoTech Inc. (AIM)

SEC filing

AIM ImmunoTech Inc.

AIM · CIK 946644

4 · Sep 16, 2026 · Director, CEO & President Equels Thomas K bought 22K shares at $0.221/share ($4,862)

Director, CEO & President Equels Thomas K bought 22K shares at $0.221/share ($4,862)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.